enadenotucirev investigational oncolytic virus clinical trials various oncolytic chimeric group b adenovirus previously described enadenotucirev also modified additional genes using tumorspecific immunogene therapy tsign platform develop novel cancer gene therapy agentscitation needed tsign vectors clinical study stage arecitation needed jan european medicines agencys ema committee orphan medical products comp designated enadenotucirev orphan medicinal product treatment ovarian two clinical trials completed enadenotucirev evolve study moa june two active phase trials octave ovarian spice multiple solid tumor indications tsign viruses ongoing clinical oncology article stub help wikipedia expanding httpsenwikipediaorgwikienadenotucirev